Get all your news in one place.
100's of premium titles.
One app.
Start reading
Medical Daily
Medical Daily
Dorothy Brooks

Eli Lilly Presses Payment Processors and Social Platforms as Federal Enforcement Struggles to Slow Retatrutide Sales

The Fight Has Moved to Banks and Feeds

The company that developed retatrutide is no longer waiting on federal regulators to shut down the market for copies of its unapproved obesity drug. It is going after the plumbing instead.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.